This file is provided for reference purposes only. It was current when it was produced, but it is no longer maintained and may now be out of date. Persons with disabilities having difficulty accessing information may
contact us for assistance. For reliable, current information on this and other health topics, we recommend consulting the NIH Clinical Center at
http://www.cc.nih.gov/.
|
Dangerous
Liaisons: Drugs and Herbal Products
Dr. Stephen Piscitelli,
Pharmacokineticist and Coordinator
Clinical Pharmacokinetics Research Laboratory, Pharmacy Department.
NIH Clinical Center
|
Tuesday,
Oct. 3, 2000 7 pm
Masur AuditoriumNIH Clinical Center
|
|
 |
Dr. Stephen C. Piscitelli
earned his Bachelor of Science degree from the State University of New York
at Buffalo, School of Pharmacy, where he also earned his Doctor of Pharmacy
degree in 1990. He completed an advanced specialty residency in infectious diseases
and a fellowship in pharmacokinetics/pharmacodynamics at the University of Illinois
at Chicago.
Since November 1996 he has
served as coordinator of the Clinical Pharmacokinetics Research Laboratory at
the Pharmacy Department of the NIH Clinical Center. Dr. Piscitelli serves in
a variety of professional settings, including adjunct assistant professor at
the University of Maryland School of Pharmacy and the Uniformed Services University
of the Health Sciences. In addition, he is a contributing editor to the HIV
Update Column of the American Journal of Health-System Pharmacy.
As part of the NIH Outreach
Program, he has also worked as a clinical pharmacist at the Upper Cardoza HIV
Clinic. He maintains his academic ties currently by teaching advanced courses
in pharmacokinetics at the University of Maryland School of Pharmacy. Previous
teaching positions included posts at the Uniformed Services University of the
Health Sciences, the University of Illinois College of Pharmacy, and SUNY at
Buffalo School of Pharmacy. He has mentored numerous pharmacy students, as well.
Dr. Piscitelli has authored
or coauthored over 100 publications, abstracts, book chapters, and web pages.
His textbook, Drug Interactions in Infectious Diseases, coedited with Keith
A. Rodvold, is expected to be published by Humana Press in September 2000. He
has been awarded numerous honors, including the Society of Infectious Diseases
Pharmacists Research Award in 1998, the American College of Clinical Pharmacy/Amgen
Research Award in Biotechnology in 1997, and the Bristol Myers Squibb Distinguished
Faculty in HIV/AIDS award in 1995.
He has held leadership positions
in professional societies including the American College of Clinical Pharmacy
and the Chesapeake College of Clinical Pharmacy, and he holds membership in
numerous others such as the American Society for Clinical Pharmacology and Therapeutics,
and the American Society of Health-System Pharmacy. Nationally, Dr. Piscitelli
has served on the IDSA/CDC Working Group on Prophylaxis of Opportunistic Infections,
the NIH Division of AIDS Expert Panel on Transplantation of HIV-infected Patients,
and the DHHS Panel on Clinical Practices for Treatment of HIV Infection, a position
he currently holds. He has been an invited lecturer at numerous national professional
symposia. Dr. Piscitelli's research interests focus on how drugs are metabolized
in the human body. Most recently, he has been evaluating interactions between
herbal products and prescription drugs, including the drug interaction between
St.John's wort and the anti-HIV medication, indinavir.
Medicine
for the Public home

The information on this page is archived and provided for reference purposes only.